Abstract: Cationic liposomes (CLs) are used as gene vectors (carriers) in worldwide human clinical trials of non-viral gene therapy. These lipid-gene complexes have the potential of transferring large pieces of DNA of up to 1 million base-pairs into cells. As our understanding of the mechanisms of action of CL-DNA complexes remains poor, transfection efficiencies are still low when compared to gene delivery with viral vectors. We describe recent studies with a combination of techniques (synchrotron x-ray diffraction for structure determination, laser-scanning confocal microscopy to probe the interactions of CL-DNA particles with cells, and luciferase reporter-gene expression assays to measure transfection efficiencies in mammalian cells), which collectively are beginning to unravel the relationship between the distinctly structured CL-DNA complexes and their transfection efficiency. The work described here is applicable to transfection optimization in ex vivo cell transfection, where cells are removed and returned to patients after transfection. CL-DNA complexes primarily form a multilayered sandwich structure with DNA layered between the cationic lipids (labeled L,~). On rare occasions, an inverted hexagonal structure with DNA encapsulated in lipid tubules (labeled H~~~) is observed. A major recent insight is that for L ,~ complexes the membrane charge density OM of the CL-vector, rather than the charge of the cationic lipid alone, is a key universal parameter that governs the transfection efficiency of L, ' complexes in cells. The parameter aM is a measure of the average charge per unit area of the membrane, thus taking into account the amount of neutral lipids. In contrast to LaC complexes, HITC complexes containing the lipid 1,2-dioleoyl-sn-glycerophosphatidylethanolamine (DOPE) exhibit no dependence on OM. The currenl limiting factor to transfection by cationic lipid vectors appears to be the tight association of a fraction of the delivered exogenous DNA with cationic cellular molecules, which may prevent optimal transcriptional activity. Future directions are outlined, which make use of surface-functionalized CL-DNA complexes suitable for transfection in vivo.
INTRODUCTION
The field of gene delivery by synthetic (non-viral) vectors continues to attract the interest of a large number of research groups, motivated mainly by the promises of gene therapy [I-71. Following initial landmark studies [&lo] , cationic liposomes (CLs; closed lipid bilayer membrane shells shown in Fig. (1) ) have been established as one of the most prevalent synthetic vectors 121. They are already used widely for in vitro transfection of mammalian cells in research applications. To enable the use of CL-DNA complexes in gene therapy, their mechanism of action is investigated extensively in many laboratories, concurrently with ongoing, mostly empirical, clinical trials, e.g. to develop cancer vaccines [l-3, 61 . Most revealing, a current compilation (Table 1) A sense of urgency for developing efficient synthetic carriers stems from the recent tragic events associated with the use of engineered adenovirus vectors. A patient died in a clinical trial due to an unanticipated severe immune response [12] . This points to an important advantage of CL-vectors over viral carriers, namely, the lack of a specific immune response due to the absence of viral peptides and proteins. In addition, in current trials using modified retrovirus vectors to treat children with severe combined immunodeficiency (SCID), a French gene therapy team faced a major setback when two patients (out of eleven) developed a blood disorder similar to leukemia. The disease was confirmed to have resulted from insertion of the transferred DNA into the initial coding region of a gene related to the early development of blood cells [13] . Moreover, while viral capsids have a maximum DNA-carrying capacity of about When solutions of DNA and cationic liposomes are combined, CL-DNA complexes form spontaneously. This is schematically illustrated in Fig. (1) . The entropy gain associated with the release of tightly bound counterions from the DNA and the lipid bilayers provides the main driving force for this process. The liposomes are made up of at least two lipids, a cationic lipid and a neutral lipid (sometimes called helper lipid). Depending on the ratio of charges on the cationic lipid and the DNA, anionic, neutral or cationic complexes are obtained. We refer to neutral complexes, where the charges on the DNA exactly match those on the cationic lipids, as isoelectric. For transfection, positively charged complexes are used, as this promotes adhesive interactions with the cell's plasma membrane (see below). In spite of the promise CLs hold as gene vectors, their transfection efficiency (TE), which is a measure of the amount of successfully transferred and transcribed DNA, remains low compared to that of viral vectors. This has spurred intense research activity aimed at enhancing TE [l-71. Maximizing the transfection efficiencies of non-viral vectors requires a full understanding of the supramolecular structures of CL-DNA complexes, their interactions with cell membranes and the events leading to release of DNA inside the cell for possible transcription. Recent synchrotron small angle x-ray diffraction (XRD) work has solved the two types of structures observed in CL-DNA complexes. These are a multilamellar structure with DNA monolayers sandwiched between cationic membranes (L,~) [14] , and an inverted hexagonal structure with DNA encapsulated within cationic lipid monolayer tubes HI^). Both structures are shown in Fig. (2) [IS]. We are now beginning to understand the parameters governing assembly and properties of the supramolecular structures of CL-DNA complexes in different lipidmembrane systems [14, 15, [19] [20] [21] [22] . The transfection efficiencies of nonviral delivery methods may be improved through these insights into transfection-related mechanisms at the molecular and self-assembled levels as we describe below.
Our work aims at unraveling the mechanisms of transfection by CL-DNA complexes at the molecular to cellular level. In particular, we focus on the influence of the structure of the complex and, within a given structure (lamellar L ,~ or inverted hexagonal H$), the chemical (e.g. membrane charge density) and physical (e.g. mechanical properties of the membrane) parameters of the membranes forming the complex. As an example, the mechanical properties of a lipid membrane are determined by its bending rigidity K and its so-called Gaussian modulus KG. The latter characterizes the tendency of a membrane to form pores; thus, CL-DNA complexes with large Gaussian moduli may show enhanced transfection efficiency because of their potential tendency to form energetically favored pores with endosoma1 membranes, releasing DNA into the cytoplasm (see e.g. Fig. (10) ). complexes. Fig. (2) . Mixing of DNA and CLs results in the spontaneous formation of CL-DNA complexes with well-defined self-assembled structures. The schematic on the left shows the local structure of their interior on the nanometer scale for the most commonly observed lamellar phase (denoted L,~). As derived from synchrotron x-ray diffraction data, the structure consists of alternating lipid bilayers and DNA monolayers. The interlayer spacing is d = 6, + 6,. For certain lipids, mixing of DNA and CLs results in the spontaneous formation of a different self-assembled structure (denoted HIIC) of CL-DNA complexes, as shown on the right. The internal structure of the inverted hexagonal HIIC phase of CL-DNA complexes is comprised of DNA coated with a lipid monolayer arranged on a hexagonal lattice, as derived from synchrotron x-ray diffraction data. Neutral and cationic lipids are depicted as having white and gray headgroups, respectively. Adapted from [14,15].
Our studies are carried out by employing synchrotron XRD for structure determination, reporter gene assays to determine transfection efficiency, and 3-dimensional laser scanning confocal microscopy (LSCM) to image complex pathways and their interactions with cells. The combination of these three characterization methods allows us to interpret the different interactions between high and low transfection efficiency complexes and cells, as observed in confocal microscopy, based on knowledge of the structure of the complexes. The experiments utilize commercially available lipids (cf. Fig. (3) ) as well as lipids with multivalent cationic head-groups that were newly synthesized for the purpose of clarifling the precise role of the membrane charge density [23, 24] .
The in vitro studies we describe in this review should apply to TE optimization in ex vivo cell transfection, where cells are removed and returned to patients after transfection. In particular, our studies aimed at understanding the key mechanisms underlying TE in continuous (dividing) cell lines should aid clinical efforts to develop efficient CLvector cancer vaccines in ex vivo applications. Those vaccines are intended to induce transient expression of genes coding for immuno-stimulatory proteins in dividing cells [2, 6, 10, 25, 261 . Thus, the nuclear membrane, which dissolves during mitosis, is not considered a barrier to the delivery and expression of DNA.
In the final "Future Directions" section of this review we outline ongoing experiments in our laboratory using a new class of surface-functionalized CL-DNA complexes, which contain recently synthesized peptide-lipids with specific sequences for targeting of the cell surface and the nucleus
[27]. As we describe, such surface-functionalized CL-DNA complexes should be suitable for future in vivo and systemic delivery studies. While the majority of our current effort is focused on optimizing transfection in continuous cell lines, we point out that experiments on non-dividing cells blocked at the GlIS point will be feasible with the surfacefunctionalized CL-DNA complexes containing peptide-lipids with a nuclear localization sequence (NLS). These experiments will serve as models of transfection in cell lines that either divide very slowly or are non-dividing (e.g. differentiated nerve cells).
THE RELATION OF MEMBRANE CHARGE DENSITY AND TRANSFECTION EFFICIENCY OF CATIONIC LIPID-DNA COMPLEXES
A critical requirement for enhancing $he transfection efficiency of synthetic carriers is a full understanding of the different structures of CL-DNA complexes and the physical and chemical basis of their interactions with cellular components. To this end, we examine the structure- There are many parameters that can be varied to optimize transfection by CL-DNA complexes, e.g. lipid structure, lipid charge, lipid to DNA charge ratio, or the amount of neutral lipid. We are particularly interested in understanding these as factors that influence the properties of the selfassembled system as a whole, enabling a generalized view.
One of these properties is the membrane charge density a~, defined as the total charge of the membrane due to the cationic lipid headgroups divided by the total area of the membrane. For isoelectric CL-DNA complexes in the L a C phase, the average spacing doNA between DNA molecules can be expressed in terms of the average distance per anionic charge along the DNA backbone (lo), and the membrane charge density OM: doNA = e/(loaM) [14, 191 . Thus, the DNA interaxial spacing is a measure of a~ and decreases as the membrane charge density increases. For positively charged complexes, a~ can no longer be directly calculated from dDNA, but the same qualitative relationship still holds.
To check whether a~ is a relevant chemical parameter of CL-DNA complexes relating to TE, we performed experiments in which we varied a M systematically for lamellar and inverted hexagonal phases. We investigated the effect on TE and also, via confocal imaging, the pathways of gene delivery into mouse L cells. The strnctures of the cationic and neutral lipids used in these first studies are given in Fig. (3) . The cationic lipids were either commercially available or gifts from other investigators. As neutral lipids, we used 1,2-dioleoyl-sn-glycerophosphatidylethanolamine (DOPE) and 1,2-dioleoyl-sn-glycerophosphatidylcholine (DoPC). DOPE is one of the main neutral lipids currently in use in gene therapy applications of CLs.
To fully explore the validity of our findings, further experiments using new, recently synthesized lipids with multivalent cationic head groups were performed [23, 24] .
Prior to our studies, TE measurements by other groups had shown that in mixtures of the monovalent cationic lipid 2,3-dioleyloxypropyltrimethylammonium chloride (DOTAP) and neutral lipids, typically at a weight ratio between 1:l and 1:3, DOPE aided, whereas DOPC severely suppressed mnsfection [28, 291. Therefore, it seemed that DOPE-based HllC complexes always transfect more efficiently than Lac complexes. Our findings show that the'difference in performarice between the two types of complexes is subtler than previously believed and that there are regimes of composition where the TE of complexes in the L a C phase becomes as high as that of the best Hrlc complexes.
In our first set of experiments, the lipid mixtures for L a C complexes ( Fig. (4) , left) were comprised of monovalent cationic DOTAP mixed with neutral DOPC. Those for H~~~ complexes ( Fig. (4) , right) contained DOTAP mixed with neutral DOPE. We used positively charged CL-DNA complexes prepared at p = DOTAPDNA (wt./wt.) = 6 with supercoiled pGL3 (luciferase gene/SV 40 promoter; from Promega Corp.) plasmid DNA. The isoelectric point, where the charges of the DNA are exactly neutralized by those of the lipid, is at p = 2.2. We chose the weight ratio p = 6, equivalent to a cationic to anionic charge ratio of 2.8, because it corresponds to the middle of a typical plateau region that is observed when ploning TE as a function of increasing p above the isoelecbic point. XRD measurements elucidated the structures of these complexes in water and in Dubellco's modified Eagle's medium (DMEM), a common environment for in vitro studies of cells [24, 38, 301 . Synchrotron small angle x-ray scattering (SAXS) patterns of DOTAPDOPC complexes at the mole fraction aDoP -0.67 ( Fig demonstrating that the TE attainable with complexes in the HllC phase at @DOPE = 0.69 is by more than two decades higher than that of L a C complexes at eDoPc = 0.67.
To tiuther understand the structure-function correlation, we examined the transfer process of CL-DNA complexes into cells and the mechanism of the subsequent DNA release using LSCM, which provides an optical resolution of -0.3 pm in the x and y, and -314 pm in the z direction. By comparing images of the x-y, y-z, and x-z planes, it is possible to determine the position of an object relative to a cell. The complexes were doubly tagged with fluorescent labels, Texas Red-DOPE for lipid and a covalently attached green label for DNA (Miis Label IT TM ) [38] . The intensity of the fluorescence sets the detection limit for DNA and lipid, which does not reach the single molecule level for uncondensed DNA. (yellow) is visible inside the cell as well as lipid-free DNA (green) in the cytoplasm. The image shows that the interaction between HllC complexes and cells leads to the dissociation of and release of DNA from the CL-vector, consistent with the measured high TE.
The corresponding confocal images for L a C complexes at @DOPE = 0.67 are shown in Fig. (5B). In striking contrast to HII complexes, we observed no free DNA. Rather, many individual intact CGDNA complexes were found inside the cells. A typical complex is highlighted in Fig. (5B). These results show that at @DoPc = 0.67, most of the DNA remains trapped by the CL-vector, consistent with the measured low TE. As there is no fluorescent lipid observed in the cell membrane, fusion is ruled out as a mechanism of cell entry. Thus, the complexes most likely entered the cells In further experiments, we observed an unexpected enhancement of the TE by two decades as the concentration of DOPC in L ,~ CL-DNA complexes was reduced. In Fig. (6A) (diamonds), the non-trivial dependence of TE on QDoPC for DOPCIDOTAP-DNA complexes is plotted. The transfection efficiency starts low for 0.5 < QDopc < 0.7 and increases dramatically to a value, at QDoPc = 0.2, which rivals that achieved by the DOPEIDOTAP-DNA H# complexes. Similar results were obtained for another univalent cationic lipid 2,3-di(myristyloxy)propyl(2-hydroxyethyl)dimethylammonium bromide (DMRIE) (Fig.  (6A) , triangles). The key experiment, which led to a deeper understanding of the observed TEs, was a study done with the multivalent cationic lipid 2,3-Dioleyloxy-N-[2- (Fig. (6A) , squares) replacing DOTAP. A qualitatively similar trend was observed, with TE decreasing rapidly above a critical However, @*DoPC was shifted from -0.2, as observed for DOTAP and DMRlE complexes, to 0.7 0.1 for DOSPA. The main difference between the cationic lipids is their headgroups (Fig. (6) , inset). The headgroup of DOSPA has a high charge of up to +5 at a size that is only somewhat larger than that of the DOTAP headgroup. Thus, the charge density (charge per unit area) of the headgroup is much higher for DOSPA and, at a given QDOPC, the membrane charge density BM in complexes containing DOSPA also is significantly larger compared to complexes prepared from DOTAP or DMRIE.
In Fig. (6B) , the same TE data as in Fig. (6A) is shown, now plotted versus the average membrane charge density OM: ~~=~~c l~( N n 1~n 1 +~c 1~c 1~[
In equation (1) we have defined r = AcIIAnl as the ratio of the head-group area of the cationic to neutral lipid, a,l = eZ/AcI as the charge density of the cationic lipid with valence Z, and @,I = NnII(NnI + NcI) and OcI = Ncl/(NnI + NC1) as the mole fractions of the neutral and cationic lipids, respectively. For the plots in Fig. (6B) , we used Ani = 72 A2 P41, DO TAP = ~D M R I E = 1, DOS SPA = 2, ZDOTAP = ZDMRIE = 1, ZDOSPA = 4 (expected for pH = 7). Since we were unable to obtain well-defined values for the head group area of cationic lipids using standard methods, r is an adjustable parameter. The values used in the plots agree well with chemical intuition (cf. also inset in Fig. (6) ). All other parameters are fixed by the experiment or the chemical structure. Given the complexity of the CL-DNA-cell system, it is remarkable that the data, spread-out when plotted as a function of Q n l in Fig. (6A) , coalesce into a single, "universal" curve as a function of OM, with TE varying exponentially over nearly four decades as OM increases by a factor of = 8 (Fig. (6B) ), a~ between 0.0015 e/A* and 0.012 elA2. This clearly implies that o~ is a key universal parameter for transfection with lamellar L ,~ CL-vectors. We now observe a single optimal oM* = 0.0104 * 0.0017 el A2 = el(100 A2) (Fig. (6B) , arrow), beyond which (OM > OM*) the universal TE curve saturates for both univalent and multivalent cat'ionic lipid containing CL-vectors. The membrane charge density OM controls the average DNA interaxial spacing dDNA (cf. Fig. (2) ) [14, 191, which was found to decrease as DM increases and level off for OM > oM* [38] . It is important to note that all TE measurements were done with 2 ~g of plasmid DNA at a constant cationic to anionic charge ratio of 2.8 (see above). Thus, every TE data point used the same amount of total charged species (anionic charge from DNA, cationic charge from cationic lipid) and only the membrane charge density of CL-DNA complexes (oM) was varied by adjusting the amount of neutral lipid. The TE data show vastly diverse behaviors for L ,~ CL-DNA complexes between low and high OM. As discussed earlier, for low = el(200 A*), corresponding to low TE, confocal images show DNA locked within complexes after endocytosis (Fig. (5B) ). To test the idea that the complexes are trapped in the endosome, we carried out transfection experiments in the presence of chloroquine. This is a wellestablished bioassay known to enhance the release of material trapped within endosomes [35] by osmotically bursting late-stage endosomes. The endocytic pathway involves lowering the pH inside the endosome and fusion of the endosome with nuclease containing lysosomes, leading to late-stage endosomes. This limits the time available for CL-DNA complexes to escape. Chloroquine is a weak organic base, which can penetrate lipid membranes in the non-protonated state. Once protonated, it can no longer difhse through the membrane and, therefore, effectively acts as a buffer selective for acidic cell compartments. As more and more protons are pumped into the buffered endosome to lower the pH, counterions follow, which eventually causes rupture of the vesicle due to the increased osmotic pressure [36] . The fractional increase (TEchloroquine/TE; note the logarithmic scale) for the DOSPAIDOPC and DOTAPIDOPC systems with added chloroquine, plotted as a function of QM in Fig. (7) , shows a large increase by as much as a factor of 60 as o~ decreases. This indicates that at low OM, lamellar LaC complexes are trapped within endosomes, consistent both with the confocal images (Fig.  (5B) ) and the measured low TE without chloroquine. At high OM, chloroquine has a much smaller effect on TE with the fractional increase of order unity, implying that endosomal entrapment is not a significant limiting factor.
A comparison of TE as a function of O M for DOTAPIDOPC-DNA and DOTAP/DOPE-DNA complexes is shown in Fig. (8) Fig. (8) . TE plotted as a function of mole fraction of nculral lipid for the DOTAPIDOPC and the DOTAPIDOPE systems. DOTAPIDOPC-DNA complexes exhibit thc L ,~ phase. As described in the text, the same amount of total charged species was used for each TE data point (which are spread out over nearly four decades) and the membrane charge density of CL-DNA complexes (aM) was varied solely by changing the amount of neutral lipid. Adapted from 1381.
W n i c L@id-DNA Conlp&xes for Gene Therapy LSCM images of cells transfected with L ,~ complexes at high OM displayed a path of complex uptake and DNA release distinct from both L,C complexes at low OM (Fig.   (SB) ) and H~~~ complexes (Fig. (5A) ). A pica1 confocal image of a cell incubated for 6 h with I . , ? complexes at aDOPC = 0.18 (oM = 0.012 e/A2) is shown in Fig. (9) . A few intact complexes are visible inside the cell: Fig. (9) (label 2; box 2) shows the equal ,green (DNA) and red (lipid) fluorescence intensity along the dotted line in the inset. More interestingly, a mass of exogenous DNA successfully transferred into the cytoplasm was also clearly evident (Fig.  (9) , label 1; box 1 shows the much larger green (DNA) fluorescence intensity along the x-y diagonal). Since there is no indication of transfer of fluorescent lipid to the plasma membrane, the complexes with high DM must have entered the cells through endocytosis. The integrated fluorescence intensity of the observed DNA (Fig. (9) , box 1) is comparable to that of DNA complexed with lipids (Fig. (9) , box 2), indicating that the released DNA is in the form of aggregates. As endosomes contain no known DNAcondensing agent, these aggregates must reside in the cytoplasm, which contains many multivalent cationic biomolecules (e.g. spermine and histones, which become available during the cell cycle) that are able to condense DNA [37]. The presence of lipid-released DNA in the cytoplasm after endocytic uptake of complexes is in agreement with the measured high TE and, moreover, implies fusion between CL-DNA lipids and endosomal ~~~~ 0 0.0 1.0 2.0 f ! ! l 0 2 4 6 8
XY -Position (pan)
XY -Position (pm) Inside Cell Fig. (9) . Typical LSCM images of a mouse L cell transfected with L ,~ complexes at mDOPC = 0.18, corresponding to cationic membranes with a high charge density o~ =: 0.012 e f p and high transfection efficiency (cf. Fig. (6) ). Rqd and green fluorescence corresponds to lipid and DNA labels, respectively; yellow, the overlap of the two, denotes CL-DNA complexes. Top: The left image is an x-y (top) view at a given z. Arrows in the side views indicate objects in circles in the x-y plane. The panels on the right are y-z side views along the vertical dashed lines in the x-y plane. Bottom: The panels on the left are x-z side views along the horizontal dashed lines in the x-y plane. In the boxes on the right, plots of lipid and DNA fluorescence intensity along the x-y diagonal or z-axis are shown. Although the lamellar complexes used here show similarly high TE, no lipid transfer to the cell plasma membrane is seen in contrast to high-transfecting H~~~ complexes (Fig. (SA) ). Both released DNA (circle "1") and intact complexes (circle "2") are observed inside the cell. Labels (3) and (4) membranes, enabling escape from the endosome. This is consistent with our finding that chloroquine has a small effect on TE at high OM, suggesting that endosomal escape is not a major obstacle. The confocal image also shows a large aggregate of complexes on part of the cell (Fig. (9) , label 3). Again, there is no transfer of fluorescent lipid to the cell membrane, which rules out entry by fusion with the plasma membrane. Comparing the changes in fluorescence intensity along the x-y-diagonal (Fig. (9) , box 3) and z-axis (Fig. (9) , box 4), from the outside toward the inside of the cell, we see an aggregate of complexes caught in the process of dissociation after endocytosis, with released DNA towards the inside of the cell.
In summary, our 3-dimensional LSCM studies have revealed distinct interactions between CL-DNA complexes and mouse L cells, both for lamellar L ,~ and inverted hexagonal HllC nanostructures. Confocal images of L ,~ complexes in cells have identified two regimes [38] . For low a~, DNA remained trapped in CL-vectors. By contrast, for high DM, released DNA was observed in the cytoplasm, indicative of escape from endosomes through fusion. TE studies using the firefly luciferase reporter gene revealed a truly unexpected result: at a constant cationic to anionic charge ratio, TE data for univalent and multivalent cationic lipids merged into a single curve as a function of OM, identifying it as a key universal parameter [38] . The universal TE curve revealed an optimal membrane charge density (DM*), where L ,~ complexes with a~ > a M * achieve TEs comparable to-that of highly transfecting H& complexes. In contrast to HllC complexes, where TE is independent of OM, the universal TE curve for L a C complexes was found to increase exponentially over nearly four decades with increasing c r~ < OM*.
A Model of Cell Entry by LaC CL Vectors: Dependence o n OM and Elastic Moduli of Cationic Membranes of CL-DNA Complexes
The combined x-ray diffraction, LSCM, and TE data lead to a model of cellular entry of L a C CL carriers Fig. (10) . Previous work indicates that the electrostatic attraction between cationic CL-DNA complexes and mammalian cells is mediated by negatively charged cell surface sulfated proteoglycans (Fig. (lo) , label a) [39] . Our LSCM images show no evidence of fusion with the plasma membrane, implying that L, C complexes enter cells via the endocytic pathway (Fig. (lo) , labels b and c). This is consistent with results of other research groups and our transfection experiments in the presence of chloroquine. Once inside the cell, L ,~ CL-DNA particles exhibit two distinct types of behavior as revealed by confocal microscopy. At low OM, mostly intact L~~ complexes are observed inside of the cells and TE experiments in the presence of chloroquine are consistent with intact complexes trapped in endosomes (Fig.  (lo) , label c). At high DM, LSCM reveals lipid-free DNA inside cells. Since the observed DNA is in a condensed state, it must reside in the cytoplasm (Fig. (lo) , label e) because of the lack of condensing molecules in the endosome [37] . This observation is consistent with TE data at high OM, where the addition of chloroquine does not increase TE.
From all our data, we conclude that in the regime where transfection efficiency scales exponentially with OM, the limiting step in the transfection process is escape from the endosome after endocytosis. The most probable mechanism for this is through fusion with the endosomal membrane (Fig. (lo), label d) . The model we propose connects this process with the membrane charge density DM of enclosed complexes. For OM < OM*, the universal TE curve (Fig.  (68) ) shows TE increasing exponentially as a function of OM and, therefore, suggests a simple model of activated fusion (showing Arrhenius behavior) of complexes with endosomal vesicles. Since fusion is the rate limiting process, TE is proportional to the rate of fusion:
with 6E = energy barrier height = a x -b.oM . Here, a, b > 0 are constants and z -I is the collision rate between the trapped CL-DNA particle and the endosomal wall (Fig. (lo) , label c). The membrane bending modulus K is a measure of the flexibility of the membrane 140-421. The larger K, the higher the energy cost associated with bending the membrane. Bending is inevitable in the fusion of membranes, as shown schematically by the arrows in the expanded view of Fig. (lo) , label d. The energy required for this, which is proportional to K, thus provides the main barrier to fusion. On the other hand, electrostatic attraction favors membrane adhesion because the fusing membranes are oppositely charged. This results in a lower energy barrier as OM increases (Fig. (lo) , label c, arrows in expanded view), corresponding to the term "-b,aM " in equation (2). The fact that higher o~ lowers the barrier height and thus appears in the exponent in equation (2) is responsible for the exponential increase of TE observed in our experiments (Fig.  (6B) ). In agreement with our model, a recent theoretical study, which considers fusion between two neutral lipid bilayers (i.e. forming pores between neighboring membranes), has found that the main energy barrier against fusion is proportional to K 1431. The same study also implies that the membrane Gaussian modulus KG should enhance fusion when KG > 0, favoring pore formation.
Current work in our group, e.g. with lipids showing a preference for cubic phases (with KG > 0), is aimed at experimentally testing the influence of and K on TE.
A Model of Cell Entry by CL-Vectors with the HllC Structure: Relevance of the Outermost Lipid Layer
A striking difference between transfection by H~~~ versus L~~ complexes is that for the former, transfection efficiency is independent of the membrane charge density OM (Fig.  (8) ). Thus, a different mechanism, which is independent of a~, must dominate the interaction between HllC complexes and cells. The lipid fluorescence, which outlines the plasma membrane in the LSCM images shown in Fig. (5A) , indicates mixing of lipids of H~~~ complexes with the plasma membrane, which may have occurred before or after entry through the endocytic athway. The image shows that DNA inside the cell is observed by confocal microscopy to be present primarily in the form of aggregates. The DNA aggregates must reside in the cytoplasm because oppositely charged cellular biomolecules able to condense DNA are not present in the endosome. Arrows in the expanded view of (c) indicate the electrostatic attraction between the oppositely charged membranes of the complex and endosome, which tends to enhance adhesion and fusion. Arrows in the expanded view of (d) indicate the bending of the membranes required for fusion, which constitutes the main barrier for the process. Adapted from [38].
may be responsible for the rapid fusion is shown schematically in Fig. (11) . In the top part, a H~~~ complex is shown approaching either the plasma or the endosomal membrane. The cell-surface proteoglycans, which again mediate the attraction between the complex and the membrane (cf. Fig. (lo) ), have been omitted for the sake of clarity. For lipids forming H~~~ complexes, the preferred membrane curvature is negative, as opposed to = 0 for lipids that form the L,~ structure. Negative curvature is realized for the lipids coating DNA inside the HIIC complex, but the curvature of the outermost lipid monolayer, which must cover the H~~~ complex to provide a hydrophilic surface, is positive. This elastically frustrated state of the outer monolayer, which is independent of OM, drives the rapid fusion with the plasma or endosomal membrane, leading to release of a layer of DNA and a smaller HrIC complex as shown in the bottom part of the Fig. (11) . In the language of our model for cell entry of L, C complexes, the activation Fig. (11) . Schematic sketch of an inverted hexagonal CL-DNA complex interacting with either the plasma membrane or the endosomal membrane. (a) The cell-surface proteoglycans of the cellular membrane (cf. Fig. (10) ) have been omitted for clarity. The outer lipid monolayer covering the HIIC CL-DNA complex has a positive curvature, whereas the preferred curvature of the cationic lipids is negative as realized in the monolayers coating DNA within the complex. Thus, the outer layer is energetically costly, which results in a driving force, independent of the cationic membrane charge density, for rapid fusion of the H# complex with the bilayer of the cell plasma membrane or the endosomal membrane as sketched in (b energy for fusion of H~~~ complexes with the endosomal membrane is negligible and this step is no longer limiting. The outer layer of the released, smaller HIIC complex is again elastically frustrated and will drive quick release of the remaining DNA through interactions with other membranes, negatively charged cellular proteins or DNA-condensin molecules. By comparison, the bilayers of lamellar La 8 complexes are inherently more stable. After escaping the endosome through fusion (see Fig. (lo), label d) , the onionlike (lipid-bilayer1DNA-monolayer) complex is expected to peel much more slowly, layer-by-layer, through interactions of the cationic membranes with anionic components of the cell, such as the predominantly anionic cytoskeletal filaments [44] , or DNA-condensing biomolecules.
Structures and Transfection Properties of New, Ornithine-Based Multivalent Cationic Lipids
To further investigate our finding of a well-defined relationship between transfection efficiency and membrane charge density OM in lamellar L ,~ complexes, and to explore more broadly the relevance of oM as a key chemical parameter, we have recently synthesized new lipids with multivalent cationic head groups, which we describe in this section. The general structure of the lipids is shown in Fig.  (12) , and the lipid head groups are compiled in Table 2 . The headgroups are based on the amino acid ornithine, whose structure is shown in Table 2 in the top-left box. A key point is that their charge was varied systematically from +2 (MVL2) to +5 (MVLS). This was achieved by the addition of propyl-mine groups to the original ornithine via Michael addition of acrylonitrile and subsequent hydrogenation [24] . A monovalent lipid (MVLI), based on glycine, was also ' prepared for comparison.
Work on one of the new multivalent cationic lipids (MVLS) shows structurally stable complexes with improved transfection efficiency behavior [24] . Optical micrographs of these CL-DNA complexes are shown in Fig. (13) , imaged in differential-interference-contrast (left), DNA fluorescence (middle) and lipid fluorescence mode (right). The complexes were prepared using DOPC/MVL5 lipid mixtures, which. contained 40 wt.-% MVL5 at a cationic lipid to DNA charge ratio of 2.8 that gives optimal transfection for complexes made from DOTAP and DOPC [38] . The observation of colocalization of lipid and DNA by fluorescence microscopy proves the formation of complexes. The structure of the CL-DNA complexes was investigated by XRD. In Fig. (14) , SAXS patterns are shown for complexes at weight h t i o n s of cationic lipid of 40% (MVL5) and 30% (DOTAP), corresponding to equivalent molar fractions of 31% and 33% of cationic lipid Fig. (12) . General structure of ornithine-based multivalent lipids. For transfection studies, we compared CL-DNA complexes prepared with DOTAP and MVL5. While the ratio of neutral to cationic lipid was varied, all complexes again had the lipid to DNA charge ratio of 2.8 optimized for the DOTAPIDOPC system. By assigning a charge of +4 to it, incomplete protonation of the MVL5 headgroup at neutral pH [45] was taken into account. Transfection experiments using mouse fibroblast L cells and a luciferase reporter assay are displayed in Fig. (15) . The new lipid MVL5 gives higher transfection efficiencies for all ratios of neutral to cationic lipid. However, the difference in transfection efficiencies increases dramatically from one to three orders of magnitude as the amount of cationic lipid is reduced from 50 to 20 mol-percent. For MVL5, the transfection effkiency exhibits a broad maximum and remains high, while it drops quickly for DOTAP. This again demonstrates the importance 
MVLS

FUTURE DIRECTIONS
Thus far we have considered CL-DNA complexes whose interactions with cells are non-specific and typically mediated by electrostatic forces. In this section we describe ongoing experiments, where directed interactions (i.e. ligand-receptor type) are added to CL-DNA complexes by incorporating peptide-lipids with specific amino acid sequences. We have recently synthesized such lipids, which contain peptides on hydrophilic poly(ethy1ene glycol) (PEG) spacers of varied length. The general structure of the peptidelipids is shown in Fig. (16) and examples of employed peptide ligands and spacers are given in Table 3 . We are pursuing two major directions in this research effort. One are CL-DNA complexes that will target the nucleus via a nuclear localization sequence. The other are complexes suitable for future systemic or in vivo studies, which will target cell surface receptors [27]. Table 3 A major continuing focus of work in our laboratory, and for a large number of other laboratories worldwide working on non-viral gene delivery systems, is on optimizing transfection at the cell level in continuous (dividing) cell lines with potential relevance for the development of cancer vaccines [I-71. Indeed, a large fraction of clinical work using CLs for delivery is centered around CL-DNA vaccines intended to induce transient expression of genes encoding for immuno-stimulatory proteins in dividing cells. The nuclear membrane, which dissolves during mitosis, is not a barrier in these experiments.
However, even cancer cells are dividing much more slowly than the cells used for in vitro experiments and some very interesting target cells for gene delivery, such as nerve cells, are non-dividing cells. Thus, vectors that are able to overcome the barrier posed by the nuclear membrane are of great interest. In the case of lamellar complexes, confocal microscopy shows that while released DNA is only at high membrane charge density, intact complex particles are present in the cell for both high and low membrane charge density Fig. (5B) and Fig. (9) . In addition, our proposed mechanism entails the release of a smaller complex particle into the cytoplasm after fusion with the endosomal membrane. Thus, intracellular targeting of a fraction of the complexes via peptide-lipids should be feasible. We are investigating whether peptide-lipids containing the NLS of the SV 40 virus [46] can mediate transport of the fraction of CL-DNA oomplexes with a particle size of less than 25 nanometers through the nuclear pore. Colloidal particles of up to 25 nm diameter, when coated with SV 40 NLS peptide-conjugated bovine serum albumin (BSA), are transported into the nuclei of HeLa cells [47, 481. While dynamic light scattering data gives a typical average CL-DNA complex size of around 100 to 150 nm, the distribution of sizes is very broad, extending down to 10s of nanometers 14, 14, IS]. The larger particles observed in microscopy are likely aggregates of smaller particles. Furthermore, cry0 electron microscopy data has shown that a fraction of complexes consists of as little as 2 to 3 lipidbilayers complexed with DNA [49] . Optimizing TE for complexes that can cross the nuclear membrane is important for future delivery applications in slowly or non-dividing cells. Once inside the nucleus, the DNA will rapidly associate with histones or polyamines. We have observed both these processes in vitro (H. M. Evans, C. R. Safinya, unpublished and [21] ).
Surface-Functionalized CL-DNA Complexes Containing RGD-Based Peptide-Lipids: CL-DNA Complexes lor in vivo Applications
The attachment of CL-DNA complexes to mammalian cells and the resulting interactions (cf. Fig. (lo) , label a) are mediated through electrostatic attractions between cationic CL-DNA complexes and negatively charged cell surface sulfated proteoglycans [39] . We are investigating an RGDpeptide with the sequence GRGDSP attached to a lipid to investigate alternative pathways of cell adhesion. The RGD sequence is expected to bind with high-affinity to the cell's surface integrins (i.e. a$, and avps), leading to receptormediated endocytosis. A main motivation for these experiments is that the concept could later be extended to more specific ligands with the aim of targeting specific cell types for systemic in vivo applications.
CL-DNA complexes, as they are currently used in ex vivo and in vivo clinical trials, the latter involving intra-tumoral injection methods [I, 21, are not suitable for systemic in vivo a~olications. Cationic lioids and their comolexes with DNA activate the complemen~ system [SO], resuiting in their rapid removal from circulation by the mononuclear phagocytic system cells through the process of opsonization. PEG-conjugation to poly(L-lysine) can reduce the activation of the complement system [50], a phenomenon well known for liposomes [Sl, 521 . The presence of a hydrophilic polymeric shell on liposomes provides a repulsive barrier and results in vastly increased circulation lifetimes, which is referred to as steric stabilization. Thus, complexes designed for systemic delivery should contain a PEG coating to prevent opsonization. However, once the PEG layer is thick enough to effectively minimize undesired interactions, the complex will also no longer attach to cells and attachment through a specific ligand (with RGD sewing as a model system) will be needed. The feasibility. of this concept has been demonstrated for liposomes with antibodies as targeting moieties 1531. 
Safiya d aL
We have performed a series of transfection and XRD experiments using PEG-lipids of various lengths. We refer to these as PEG Mw -lipids, where MW is the molecular weight of the PEG chain. Recent x-ray data show that CL-DNA complexes containing PEG2000-lipid, shown schematically in the top part of Fig. (17) , are indeed structurally stable, and thus suitable candidates for the incorporation of additional RGD-PEG-lipids [54] . To demonstrate that the PEG2000-lipid is also exposed at the complex surface, we conducted TE measurements of highly transfecting CL-DNA complexes (80 mol-% DOTAP) as a function of increasing amount of incorporated PEG-lipid (Fig. (17), bottom) . The addition of about 6 mol-% PEG zooo -lipid already leads to a strong suppression of TE, by about 2 orders of magnitude. This indicates that the electrostatic binding of the cationic CL-DNA complex to cells is efficiently reduced due to the PEG2000 polymer coat of thickness = 35 A [3 11. In contrast, the shorter PEG chain of a PEG400-lipid does not provide significant shielding of the electrostatic interactions and TE remains relatively high. Note the difference in mol-fraction for the PEG-lipids, which correspond to approximately equal total amounts of PEG.
We are now investigating surface-functionalized CL-DNA complexes, which incorporate a mixture of PEG2000-lipids and RGD-PEG zooo -lipids within their membranes. The RGD-peptide should provide an effective ligand for the integrin receptors on the cell surface. For such functionalized CL-DNA complexes, the primary role of the cationic lipid is the condensation of DNA. This is in contrast to standard CL-DNA complexes, where the cationic lipids both condense DNA and provide for electrostatic attachment to the cell surface. Therefore, the new complexes are not only designed to be suitable for systemic in vivo applications due to their steric stabilization, but the reduced amount of cationic lipid will also reduce their toxicity.
. '
CONCLUSIONS
The broad, long-term objective of our research is to develop a fundamental science base, which will lead to design and synthesis of optimal nonviral carriers of DNA for gene therapy. Simultaneously, a major long term objective is to improve efficiency for delivering large pieces of DNA containing important human genes and their regulatory sequences (> 100 k-base-pairs), which at present can only be achieved with synthetic vectors. The structure-function data obtained from our research should allow us to begin the formidable task of rationally designing these self assemblies for enhanced gene delivery, beginning with the chemical structure of the lipids and the appropriate lipid compositions.
Our work has shown that CL-DNA complexes of distinct structure (i.e. L ,~ versus H~~C ) differ widely in their interactions with cells and their ability to deliver exogenous DNA to the cytoplasm. We have demonstrated that OM, the average membrane charge density of the CL-vector, is a key universal parameter that governs the transfection behavior of L ,~ complexes in cells. The universal TE curve for DOPCcontaining L ,~ complexes increases exponentially with OM for ISM < oM* (the optimal membrane charge density), and saturates for OM > oM*. The limiting saturated TE level of L ,~ complexes is comparable to the high TE of DOPEcontaining HIIC complexes, which exhibit no dependence on OM. For both L ,~ and HrrC complexes, confocal microscopy reveals that much of the lipid-released DNA is in a condensed state and, therefore, has to contain oppositely charged macro-ion condensing agents from the cytoplasm. While DNA strands covering the surface of the DNA mass or isolated from it are most likely transcriptionally active, much of the observed bulk of condensed DNA may be transcriptionally inactive, probably setting the current limit to transfection by cationic lipid vectors. Future studies should reveal well-defined structure-function correlations for transfection in vivo, in particular, for local intra-tumoral injection in clinical studies. 
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